Recombinant, tumour-derived idiotype vaccination for indolent Bcell non-Hodgkin’s lymphomas: a focus on FavId™

Author: Hurvitz Sara A   Timmerman John M  

Publisher: Informa Healthcare

ISSN: 1471-2598

Source: Expert Opinion on Biological Therapy, Vol.5, Iss.6, 2005-06, pp. : 841-852

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content